Unknown

Dataset Information

0

Tumoral immune suppression by macrophages expressing fibroblast activation protein-? and heme oxygenase-1.


ABSTRACT: The depletion of tumor stromal cells that are marked by their expression of the membrane protein fibroblast activation protein-? (FAP) overcomes immune suppression and allows an anticancer cell immune response to control tumor growth. In subcutaneous tumors established with immunogenic Lewis lung carcinoma cells expressing ovalbumin (LL2/OVA), the FAP(+) population is comprised of CD45(+) and CD45(-) cells. In the present study, we further characterize the tumoral FAP(+)/CD45(+) population as a minor subpopulation of F4/80(hi)/CCR2(+)/CD206(+) M2 macrophages. Using bone marrow chimeric mice in which the primate diphtheria toxin receptor is restricted either to the FAP(+)/CD45(+) or to the FAP(+)/CD45(-) subset, we demonstrate by conditionally depleting each subset that both independently contribute to the immune-suppressive tumor microenvironment. A basis for the function of the FAP(+)/CD45(+) subset is shown to be the immune inhibitory enzyme, heme oxygenase-1 (HO-1). The FAP(+)/CD45(+) cells are the major tumoral source of HO-1, and an inhibitor of HO-1, Sn mesoporphyrin, causes the same extent of immune-dependent arrest of LL2/OVA tumor growth as does the depletion of these cells. Because this observation of immune suppression by HO-1 expressed by the FAP(+)/CD45(+) stromal cell is replicated in a transplanted model of pancreatic ductal adenocarcinoma, we conclude that pharmacologically targeting this enzyme may improve cancer immunotherapy.

SUBMITTER: Arnold JN 

PROVIDER: S-EPMC4007628 | biostudies-literature | 2014 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Tumoral immune suppression by macrophages expressing fibroblast activation protein-α and heme oxygenase-1.

Arnold James N JN   Magiera Lukasz L   Kraman Matthew M   Fearon Douglas T DT  

Cancer immunology research 20131118 2


The depletion of tumor stromal cells that are marked by their expression of the membrane protein fibroblast activation protein-α (FAP) overcomes immune suppression and allows an anticancer cell immune response to control tumor growth. In subcutaneous tumors established with immunogenic Lewis lung carcinoma cells expressing ovalbumin (LL2/OVA), the FAP(+) population is comprised of CD45(+) and CD45(-) cells. In the present study, we further characterize the tumoral FAP(+)/CD45(+) population as a  ...[more]

Similar Datasets

| S-EPMC2956932 | biostudies-literature
| S-EPMC4900522 | biostudies-literature
| S-EPMC3132305 | biostudies-literature
| S-EPMC6557132 | biostudies-literature
| S-EPMC3422740 | biostudies-literature
| S-EPMC8267680 | biostudies-literature
| S-EPMC7308058 | biostudies-literature
| S-EPMC4582649 | biostudies-literature
2020-06-29 | GSE148585 | GEO
| S-EPMC4556412 | biostudies-literature